2024 Q2 Form 10-Q Financial Statement
#000165495424006412 Filed on May 15, 2024
Income Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
Revenue | $0.00 | $0.00 |
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $510.9K | $399.6K |
YoY Change | -30.69% | -29.64% |
% of Gross Profit | ||
Research & Development | $19.45K | $19.45K |
YoY Change | -50.46% | -73.63% |
% of Gross Profit | ||
Depreciation & Amortization | ||
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | $530.3K | $419.1K |
YoY Change | -31.69% | -34.7% |
Operating Profit | -$419.1K | |
YoY Change | -34.7% | |
Interest Expense | -$72.72K | $74.71K |
YoY Change | 57.98% | 268.68% |
% of Operating Profit | ||
Other Income/Expense, Net | -$59.01K | |
YoY Change | -34.69% | |
Pretax Income | -$603.0K | -$478.1K |
YoY Change | -26.4% | -34.7% |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | $27.11K | -$478.1K |
YoY Change | -102.81% | -34.7% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | ||
Diluted Earnings Per Share | $0.00 | -$0.01 |
COMMON SHARES | ||
Basic Shares Outstanding | 188.2M shares | 105.8M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $8.460K | $8.250K |
YoY Change | -15.23% | -82.35% |
Cash & Equivalents | $8.456K | $8.247K |
Short-Term Investments | ||
Other Short-Term Assets | $19.45K | |
YoY Change | 11.14% | |
Inventory | ||
Prepaid Expenses | $19.45K | |
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $8.456K | $27.69K |
YoY Change | -15.29% | -56.9% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | ||
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $0.00 | $0.00 |
YoY Change | ||
TOTAL ASSETS | ||
Total Short-Term Assets | $8.456K | $27.69K |
Total Long-Term Assets | $0.00 | $0.00 |
Total Assets | $8.456K | $27.69K |
YoY Change | -15.29% | -56.9% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $1.095M | $1.063M |
YoY Change | 29.45% | 60.75% |
Accrued Expenses | $2.526M | $2.346M |
YoY Change | 31.59% | 44.4% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $1.312M | $1.327M |
YoY Change | -0.4% | -25.27% |
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $5.157M | $4.937M |
YoY Change | 20.97% | 14.4% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | ||
YoY Change | ||
Total Long-Term Liabilities | $0.00 | $0.00 |
YoY Change | ||
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $5.157M | $4.937M |
Total Long-Term Liabilities | $0.00 | $0.00 |
Total Liabilities | $5.157M | $4.937M |
YoY Change | 20.97% | 14.4% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$62.75M | -$62.77M |
YoY Change | 4.81% | 6.31% |
Common Stock | $21.40K | $12.65K |
YoY Change | 616.34% | 2162.61% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$5.149M | -$4.910M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $8.456K | $27.69K |
YoY Change | -15.29% | -56.9% |
Cashflow Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | $27.11K | -$478.1K |
YoY Change | -102.81% | -34.7% |
Depreciation, Depletion And Amortization | ||
YoY Change | ||
Cash From Operating Activities | -$120.8K | -$100.3K |
YoY Change | 69.74% | -42.54% |
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | ||
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 121.0K | 100.1K |
YoY Change | 251.89% | -47.31% |
NET CHANGE | ||
Cash From Operating Activities | -120.8K | -100.3K |
Cash From Investing Activities | ||
Cash From Financing Activities | 121.0K | 100.1K |
Net Change In Cash | 210.0 | -230.0 |
YoY Change | -100.57% | -101.5% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$120.8K | -$100.3K |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q2 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
0 | usd |
CY2024Q1 | us-gaap |
Assets Current
AssetsCurrent
|
27693 | usd |
CY2023Q2 | us-gaap |
Assets
Assets
|
9982 | usd |
CY2023Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
845502 | usd |
CY2023Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1371879 | usd |
CY2024Q1 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
512621 | usd |
CY2023Q2 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
548041 | usd |
CY2024Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
1062823 | usd |
CY2024Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1833529 | usd |
CY2024Q1 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
675924 | usd |
CY2023Q2 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
937576 | usd |
CY2023Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
55597779 | usd |
CY2023Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-59869400 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4253314 | usd |
CY2023Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
9982 | usd |
CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
8247 | usd |
CY2024Q1 | us-gaap |
Assets
Assets
|
27693 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
18084 | usd |
CY2024Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
19446 | usd |
CY2024Q1 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
23211 | usd |
CY2023Q2 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
80707 | usd |
CY2024Q1 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
650603 | usd |
CY2023Q2 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
380013 | usd |
CY2024Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4937344 | usd |
CY2023Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4263296 | usd |
CY2024Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
57836980 | usd |
CY2024Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-62774599 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4909651 | usd |
CY2024Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
27693 | usd |
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001082733 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--06-30 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | ||
CY2023Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | shares |
CY2023Q2 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | usd |
CY2023Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
48018 | usd |
CY2023Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
512542 | usd |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
|
0 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
|
0 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares | |
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
0 | shares | |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-03-31 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
000-25753 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
VISIUM TECHNOLOGIES, INC. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
FL | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
87-0449667 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
4094 MAJESTIC LANE | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
SUITE 360 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
FAIRFAX | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
VA | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
22033 | ||
dei |
City Area Code
CityAreaCode
|
703 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
273-0383 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2024Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
188218508 | shares |
CY2023Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
9982 | usd |
CY2023Q2 | us-gaap |
Assets Current
AssetsCurrent
|
9982 | usd |
CY2024Q1 | vism |
Due From Officers Stockholders
DueFromOfficersStockholders
|
178633 | usd |
CY2023Q2 | vism |
Due From Officers Stockholders
DueFromOfficersStockholders
|
99578 | usd |
CY2024Q1 | us-gaap |
Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
|
10984 | usd |
CY2023Q2 | us-gaap |
Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
|
0 | usd |
CY2024Q1 | vism |
Notes Payable Net Of Discount
NotesPayableNetOfDiscount
|
14866 | usd |
CY2023Q2 | vism |
Notes Payable Net Of Discount
NotesPayableNetOfDiscount
|
26805 | usd |
CY2024Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | shares |
CY2024Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
126480567 | shares |
CY2024Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
126472250 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
37199647 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
29844713 | shares |
CY2024Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
12648 | usd |
CY2023Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
2987 | usd |
CY2024Q1 | us-gaap |
Revenues
Revenues
|
0 | usd |
CY2023Q1 | us-gaap |
Revenues
Revenues
|
0 | usd |
us-gaap |
Revenues
Revenues
|
0 | usd | |
us-gaap |
Revenues
Revenues
|
0 | usd | |
CY2024Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
399604 | usd |
CY2023Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
567979 | usd |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1990912 | usd | |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1461560 | usd | |
CY2024Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
19447 | usd |
CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
73755 | usd |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
67256 | usd | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
175707 | usd | |
CY2024Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
419051 | usd |
CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
641734 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
2058168 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
1637267 | usd | |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-419051 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-641734 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2058168 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1637267 | usd | |
CY2024Q1 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
24807 | usd |
CY2023Q1 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-50384 | usd |
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
57496 | usd | |
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-84246 | usd | |
CY2024Q1 | vism |
Derivative Liability Expense
DerivativeLiabilityExpense
|
0 | usd |
CY2023Q1 | vism |
Derivative Liability Expense
DerivativeLiabilityExpense
|
4634 | usd |
vism |
Derivative Liability Expense
DerivativeLiabilityExpense
|
0 | usd | |
vism |
Derivative Liability Expense
DerivativeLiabilityExpense
|
62773 | usd | |
CY2024Q1 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-9106 | usd |
CY2023Q1 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-15068 | usd |
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-21141 | usd | |
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-519993 | usd | |
CY2024Q1 | us-gaap |
Interest Expense
InterestExpense
|
74712 | usd |
CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
20265 | usd |
us-gaap |
Interest Expense
InterestExpense
|
253256 | usd | |
us-gaap |
Interest Expense
InterestExpense
|
187205 | usd | |
CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-59011 | usd |
CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-90354 | usd |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-216901 | usd | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-854217 | usd | |
CY2024Q1 | vism |
Net Income Losses
NetIncomeLosses
|
-478062 | usd |
CY2023Q1 | vism |
Net Income Losses
NetIncomeLosses
|
-732085 | usd |
vism |
Net Income Losses
NetIncomeLosses
|
-2275069 | usd | |
vism |
Net Income Losses
NetIncomeLosses
|
-2491484 | usd | |
CY2024Q1 | us-gaap |
Dividends Common Stock Stock
DividendsCommonStockStock
|
145670 | usd |
CY2023Q1 | us-gaap |
Dividends Common Stock Stock
DividendsCommonStockStock
|
0 | usd |
us-gaap |
Dividends Common Stock Stock
DividendsCommonStockStock
|
630130 | usd | |
us-gaap |
Dividends Common Stock Stock
DividendsCommonStockStock
|
0 | usd | |
CY2024Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-623732 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-732085 | usd |
us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-2905199 | usd | |
us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-2491484 | usd | |
CY2024Q1 | vism |
Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
|
-0.01 | |
CY2023Q1 | vism |
Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
|
-0.16 | |
vism |
Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
|
-0.04 | ||
vism |
Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
|
-0.72 | ||
CY2024Q1 | vism |
Weighted Average Number Of Diluted Shares Outstanding1
WeightedAverageNumberOfDilutedSharesOutstanding1
|
108132383 | shares |
CY2023Q1 | vism |
Weighted Average Number Of Diluted Shares Outstanding1
WeightedAverageNumberOfDilutedSharesOutstanding1
|
4658570 | shares |
vism |
Weighted Average Number Of Diluted Shares Outstanding1
WeightedAverageNumberOfDilutedSharesOutstanding1
|
74327012 | shares | |
vism |
Weighted Average Number Of Diluted Shares Outstanding1
WeightedAverageNumberOfDilutedSharesOutstanding1
|
3454032 | shares | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4724913 | usd |
CY2024Q1 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
111787 | usd |
CY2024Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
181537 | usd |
CY2024Q1 | us-gaap |
Dividends Common Stock
DividendsCommonStock
|
0 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-478062 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4909651 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4253314 | usd |
us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
417887 | usd | |
vism |
Shares Issued As Compensation To Employees Amount
SharesIssuedAsCompensationToEmployeesAmount
|
89407 | usd | |
vism |
Shares Issued As Compensation To Directors And Officers Amount
SharesIssuedAsCompensationToDirectorsAndOfficersAmount
|
520624 | usd | |
us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
590814 | usd | |
us-gaap |
Dividends Common Stock
DividendsCommonStock
|
0 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2275069 | usd | |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4909651 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3997400 | usd |
CY2023Q1 | vism |
Shares Issued As Compensation To Employees Amount
SharesIssuedAsCompensationToEmployeesAmount
|
71300 | usd |
CY2023Q1 | vism |
Shares Issued As Compensation To Directors And Officers Amount
SharesIssuedAsCompensationToDirectorsAndOfficersAmount
|
161200 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
213418 | usd |
CY2023Q1 | vism |
Commitment Shares Issued Pursuant To Financing Amount
CommitmentSharesIssuedPursuantToFinancingAmount
|
14000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-732085 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4251487 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2793558 | usd |
us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
36956 | usd | |
vism |
Shares Issued As Compensation To Employees Amount
SharesIssuedAsCompensationToEmployeesAmount
|
144150 | usd | |
vism |
Shares Issued As Compensation To Directors And Officers Amount
SharesIssuedAsCompensationToDirectorsAndOfficersAmount
|
361013 | usd | |
vism |
Gains Losse On Extinguishment Of Debt
GainsLosseOnExtinguishmentOfDebt
|
186972 | usd | |
vism |
Shares Issued For Conversion Of Notes Payable And Accrued Interest Amount
SharesIssuedForConversionOfNotesPayableAndAccruedInterestAmount
|
290464 | usd | |
vism |
Commitment Shares Issued Pursuant To Financing Amount
CommitmentSharesIssuedPursuantToFinancingAmount
|
14000 | usd | |
vism |
Shares Issued For Exercise Of Warrants Amount
SharesIssuedForExerciseOfWarrantsAmount
|
0 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2491484 | usd | |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4251487 | usd |
us-gaap |
Profit Loss
ProfitLoss
|
2275069 | usd | |
us-gaap |
Profit Loss
ProfitLoss
|
2491484 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1027918 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
542149 | usd | |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
32355 | usd | |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
83218 | usd | |
vism |
Derivative Liability Expense
DerivativeLiabilityExpense
|
0 | usd | |
vism |
Derivative Liability Expense
DerivativeLiabilityExpense
|
62773 | usd | |
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
57496 | usd | |
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-84246 | usd | |
vism |
Losses On Extinguishment Of Debt
LossesOnExtinguishmentOfDebt
|
-21141 | usd | |
vism |
Losses On Extinguishment Of Debt
LossesOnExtinguishmentOfDebt
|
-519993 | usd | |
us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
236568 | usd | |
us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
37812 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
19446 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
17500 | usd | |
us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
-204830 | usd | |
us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
-150008 | usd | |
us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
461650 | usd | |
us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
576045 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-367549 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-452740 | usd | |
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
335000 | usd | |
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
150000 | usd | |
us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
97392 | usd | |
us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
0 | usd | |
us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
133000 | usd | |
us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
140000 | usd | |
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
83849 | usd | |
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | usd | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
79055 | usd | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
72500 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
365814 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
362500 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-1735 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-90240 | usd | |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
9982 | usd |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
136990 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
8247 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
46750 | usd |
us-gaap |
Interest Paid Net
InterestPaidNet
|
8531 | usd | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd | |
vism |
Issuance Of Common Stock For Conversion Of Notes Payable And Accrued Interest
IssuanceOfCommonStockForConversionOfNotesPayableAndAccruedInterest
|
590814 | usd | |
vism |
Issuance Of Common Stock For Conversion Of Notes Payable And Accrued Interest
IssuanceOfCommonStockForConversionOfNotesPayableAndAccruedInterest
|
290464 | usd | |
vism |
Commitment Shares Issued For Financing
CommitmentSharesIssuedForFinancing
|
0 | usd | |
vism |
Commitment Shares Issued For Financing
CommitmentSharesIssuedForFinancing
|
14000 | usd | |
vism |
Warrants Issued On Extinguishment Of Debt
WarrantsIssuedOnExtinguishmentOfDebt
|
0 | usd | |
vism |
Warrants Issued On Extinguishment Of Debt
WarrantsIssuedOnExtinguishmentOfDebt
|
186972 | usd | |
us-gaap |
Fiscal Period
FiscalPeriod
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fiscal year ends on June 30. References to fiscal year 2024, for example, refer to the fiscal year ending June 30, 2024.</p> | ||
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions used in Cox, Ross & Rubinstein Binomial Tree stock-based compensation valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate and in the valuation allowance of deferred tax assets and derivative liability.</p> | ||
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is subject to a concentration of credit risk from cash.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s cash account is held at a financial institution and is insured by the Federal Deposit Insurance Corporation, or FDIC, up to $250,000. As of March 31, 2024 and June 30, 2023, the Company did not exceed these FDIC limits.</p> | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
74327012 | shares | |
CY2023 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6306120 | shares |
vism |
Incremental Common Shares Attributable To Common Stock Option
IncrementalCommonSharesAttributableToCommonStockOption
|
2222 | shares | |
us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
5114576 | shares | |
vism |
Annually Prepaid License Fee
AnnuallyPrepaidLicenseFee
|
77850 | usd | |
us-gaap |
Proceeds From License Fees Received
ProceedsFromLicenseFeesReceived
|
19446 | usd | |
us-gaap |
Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
|
57496 | usd | |
us-gaap |
Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
|
84246 | usd | |
CY2024Q1 | vism |
Fair Value Of Warrant
FairValueOfWarrant
|
0 | usd |
CY2023Q2 | vism |
Fair Value Of Warrant
FairValueOfWarrant
|
0 | usd |
CY2024Q1 | us-gaap |
Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
|
23211 | usd |
CY2023Q2 | us-gaap |
Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
|
80707 | usd |
CY2024Q1 | vism |
Derivative Liabilities Fair Value Assumptions Exercise Price
DerivativeLiabilitiesFairValueAssumptionsExercisePrice
|
0.0026 | |
CY2024Q1 | vism |
Derivative Liabilities Fair Value Assumptions Market Price
DerivativeLiabilitiesFairValueAssumptionsMarketPrice
|
0.0039 | |
CY2023Q1 | vism |
Derivative Liabilities Fair Value Assumptions Market Price
DerivativeLiabilitiesFairValueAssumptionsMarketPrice
|
0.1945 | |
vism |
Derivative Liabilities Fair Value Assumptions Expected Volatility Rate
DerivativeLiabilitiesFairValueAssumptionsExpectedVolatilityRate
|
1.5653 | pure | |
vism |
Derivative Liabilities Fair Value Assumptions Expected Volatility Rate
DerivativeLiabilitiesFairValueAssumptionsExpectedVolatilityRate
|
3.033 | pure | |
vism |
Derivative Liabilities Fair Value Assumptions Risk Free Interest Rate
DerivativeLiabilitiesFairValueAssumptionsRiskFreeInterestRate
|
0.0548 | pure | |
vism |
Derivative Liabilities Fair Value Assumptions Risk Free Interest Rate
DerivativeLiabilitiesFairValueAssumptionsRiskFreeInterestRate
|
0.0479 | pure | |
vism |
Derivative Liabilities Fair Value Assumptions Expected Term
DerivativeLiabilitiesFairValueAssumptionsExpectedTerm
|
P60D | ||
vism |
Expected Dividend Rate
ExpectedDividendRate
|
0 | pure | |
vism |
Expected Dividend Rate
ExpectedDividendRate
|
0 | pure | |
CY2023Q2 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
548041 | usd |
CY2023Q2 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
80707 | usd |
us-gaap |
Liability For Future Policy Benefits Period Expense
LiabilityForFuturePolicyBenefitsPeriodExpense
|
0 | usd | |
vism |
Loss On Change In Fair Value Of Derivative Liabilities
LossOnChangeInFairValueOfDerivativeLiabilities
|
-57496 | usd | |
CY2024Q1 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
23211 | usd |
CY2024Q1 | vism |
Convertible Notes Payable1
ConvertibleNotesPayable1
|
686908 | usd |
CY2023Q2 | vism |
Convertible Notes Payable1
ConvertibleNotesPayable1
|
937576 | usd |
CY2024Q1 | vism |
Discount On Convertible Notes Payable
DiscountOnConvertibleNotesPayable
|
-10984 | usd |
CY2023Q2 | vism |
Discount On Convertible Notes Payable
DiscountOnConvertibleNotesPayable
|
0 | usd |
CY2024Q1 | vism |
Convertible Notes Payable To Related Parties Current
ConvertibleNotesPayableToRelatedPartiesCurrent
|
675924 | usd |
CY2023Q2 | vism |
Convertible Notes Payable To Related Parties Current
ConvertibleNotesPayableToRelatedPartiesCurrent
|
937576 | usd |
CY2024Q1 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
675924 | usd |
CY2023Q2 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
937576 | usd |
vism |
Scheduleofconvertible Notes Payabletabletextblock
ScheduleofconvertibleNotesPayabletabletextblock
|
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible notes payable at June 30, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">937,576</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible notes issued during the nine months ended March 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">133,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible notes repaid in cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(76,250 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Short term loan amended to be convertible note payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Discount related to convertible notes payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(10,984 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Conversion of convertible notes payable into common stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(331,317 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Convertible notes payable at March 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">675,924</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> | ||
CY2023Q2 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
937576 | usd |
vism |
Convertible Notes Issued55
ConvertibleNotesIssued55
|
133000 | usd | |
vism |
Convertible Notes Repaid In Cash
ConvertibleNotesRepaidInCash
|
-76250 | usd | |
vism |
Short Term Loan Amended To Be Convertible Note Payable
ShortTermLoanAmendedToBeConvertibleNotePayable
|
10000 | usd | |
vism |
Discount Related To Convertible Notes Payable
DiscountRelatedToConvertibleNotesPayable
|
-10984 | usd | |
vism |
Conversion Of Convertible Notes Payable Into Common Stock
ConversionOfConvertibleNotesPayableIntoCommonStock
|
-331317 | usd | |
CY2024Q1 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
675924 | usd |
us-gaap |
Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
|
47163371 | shares | |
vism |
Convertible Notes Payable Principle Amount
ConvertibleNotesPayablePrincipleAmount
|
331317 | usd | |
us-gaap |
Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
|
240257 | usd | |
vism |
Convertible Notes Payable Conversion Expense
ConvertibleNotesPayableConversionExpense
|
19250 | usd | |
us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
590814 | usd | |
us-gaap |
Common Stock Convertible Conversion Price Increase
CommonStockConvertibleConversionPriceIncrease
|
0.0125 | ||
vism |
Loss On Extinguishments Of Debt Related To Payoff Of Convertible Note
LossOnExtinguishmentsOfDebtRelatedToPayoffOfConvertibleNote
|
21141 | shares | |
vism |
Loss On Extinguishment Of Debt Related To Payoff Of Convertible Note
LossOnExtinguishmentOfDebtRelatedToPayoffOfConvertibleNote
|
-21141 | shares | |
vism |
Gain On Extinguishment Of Debt Amount
GainOnExtinguishmentOfDebtAmount
|
-21141 | usd | |
vism |
Common Stock Convertible Conversion Prices Increase
CommonStockConvertibleConversionPricesIncrease
|
2.43 | ||
vism |
Dividend Common Stock
DividendCommonStock
|
630130 | usd | |
CY2024Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | shares |
CY2024Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
126480567 | shares |
CY2024Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
126472250 | shares |
vism |
Unvested Shares Issued For The Restricted Stock
UnvestedSharesIssuedForTheRestrictedStock
|
8309 | shares | |
us-gaap |
Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
|
519993 | usd | |
us-gaap |
Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
|
5048426 | shares | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
|
5115207 | shares |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.025 | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
|
631 | shares | |
vism |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price Warrant
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePriceWarrant
|
10.395 | ||
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
|
5114576 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.023 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
5114576 | shares |
CY2024Q1 | vism |
Share Based Compensations Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationsArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0.023 | |
CY2024Q1 | vism |
Class Of Warrants Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantsOrRightExercisePriceOfWarrantsOrRights1
|
0.0169 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
|
5114576 | shares |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P3DT10H | ||
CY2024Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.023 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
5114576 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0.023 | |
us-gaap |
Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
|
11852000000 | shares | |
CY2023Q4 | us-gaap |
Share Price
SharePrice
|
20.25 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0 | pure | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0 | pure |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0 | pure | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0 | pure |
vism |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
|
0 | pure | |
CY2023 | vism |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
|
0 | pure |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2222 | shares |
CY2023Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
|
27.00 | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | usd |
CY2023Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
0 | usd |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
7297475 | shares |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
0.0536 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
250000 | shares | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
8309 | shares |
CY2024Q1 | vism |
Due To Officers Current
DueToOfficersCurrent
|
178633 | usd |
vism |
Accrued Payrolldisclosuretextblock
AccruedPayrolldisclosuretextblock
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 10 - ACCRUED COMPENSATION</strong> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accrued compensation consist of the following at:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024 </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023 </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued compensation - officers</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,082,762</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">900,846</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued compensation - staff</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">750,767</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">471,033</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,833,529</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,371,879</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> | ||
CY2024Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1833529 | usd |
CY2023Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1371879 | usd |